These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14727978)

  • 1. Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
    Mann JF; Gerstein HC; Pogue J; Lonn E; Yusuf S
    Am J Cardiovasc Drugs; 2002; 2(3):157-62. PubMed ID: 14727978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.
    Mann JF
    Presse Med; 2005 Oct; 34(18):1303-8. PubMed ID: 16269994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in patients with mild renal insufficiency.
    Mann JF; Gerstein HC; Dulau-Florea I; Lonn E
    Kidney Int Suppl; 2003 May; (84):S192-6. PubMed ID: 12694342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What have we learned from the current trials?
    Abbott KC; Bakris GL
    Med Clin North Am; 2004 Jan; 88(1):189-207. PubMed ID: 14871059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
    Mann JF; Gerstein HC; Pogue J; Bosch J; Yusuf S
    Ann Intern Med; 2001 Apr; 134(8):629-36. PubMed ID: 11304102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
    Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.
    Lancet; 2000 Jan; 355(9200):253-9. PubMed ID: 10675071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE.
    Heinig RE
    Diabetes Obes Metab; 2002 Jan; 4 Suppl 1():S19-25. PubMed ID: 11843951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.
    Mann JF; Yi QL; Sleight P; Dagenais GR; Gerstein HC; Lonn EM; Bosch J;
    Clin Nephrol; 2005 Mar; 63(3):181-7. PubMed ID: 15786818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.
    Knoll GA; Cantarovitch M; Cole E; Gill J; Gourishankar S; Holland D; Kiberd B; Muirhead N; Prasad R; Tibbles LA; Treleaven D; Fergusson D
    Nephrol Dial Transplant; 2008 Jan; 23(1):354-8. PubMed ID: 17848393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
    Teo K; Yusuf S; Sleight P; Anderson C; Mookadam F; Ramos B; Hilbrich L; Pogue J; Schumacher H;
    Am Heart J; 2004 Jul; 148(1):52-61. PubMed ID: 15215792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ONTARGET/TRANSCEND Trial Programme: baseline data.
    Sleight P
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S50-6. PubMed ID: 15868120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
    Schädlich PK; Brecht JG; Rangoonwala B; Huppertz E
    Pharmacoeconomics; 2004; 22(15):955-73. PubMed ID: 15449961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors.
    Böhm M; Baumhäkel M; Mahfoud F; Werner C
    Cardiology; 2010; 117(3):163-73. PubMed ID: 21051889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.